Total Funding
32
62
Total FundingPost-IPO Debt raised
Growth Score 32 in past quarter
0 pts
Heat Score 62 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
258427
Canntab Therapeutics is a biopharmaceutical company that aims at manufacturing & distributing hard pill cannabinoid formulations.
- Larry Latowsky: CEO
About the Company
Canntab's revolutionary medical cannabis delivery system sets a new benchmark for patient convenience and experience. Other approaches, in comparison, do not have the same therapeutic effect.